Hartford Investment Management Co (HIMCO)’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-3,995
Closed -$254K 621
2015
Q3
$254K Sell
3,995
-345
-8% -$22.7K 0.01% 555
2015
Q2
$277K Buy
4,340
+10
+0.2% +$685 0.01% 558
2015
Q1
$296K Buy
4,330
+261
+6% +$18.1K 0.01% 551
2014
Q4
$286K Buy
4,069
+1,063
+35% +$76.1K 0.01% 583
2014
Q3
$215K Buy
+3,006
New +$220K ﹤0.01% 692

Other funds holding AZN

Hartford Investment Management Co (HIMCO)'s AZN Position: Q4 2015 in Review

Hartford Investment Management Co (HIMCO) sold out of AstraZeneca (AZN) in Q4 2015, closing a stake of 3,995 shares — an estimated $254K sold.

Hartford Investment Management Co (HIMCO) first reported a position in AZN in Q3 2014 and held it in 5 quarters. The position peaked at $296K in Q1 2015. 390 funds tracked by Wall St. Rank hold AZN as of Q4 2015.

  • Hartford Investment Management Co (HIMCO) reported no remaining AstraZeneca position as of Q4 2015 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 3,995 AstraZeneca shares in Q4 2015, an estimated $254K.
  • Hartford Investment Management Co (HIMCO) first reported a position in AstraZeneca in Q3 2014 and held it in 5 quarters.
  • Hartford Investment Management Co (HIMCO)'s AstraZeneca position peaked at $296K in Q1 2015.
  • 390 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2015.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q4 2015, filed 11 Feb 2016.